Ray Dalio’s Arrowhead Research ARWR Stock Holding History

Ray Dalio’s Portfolio ARWR Stock Details ARWR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.99M	Buy	95,552 +35,586	+59%	+$2.25M	0.03%	378
2025 Q4	$3.98M	Buy	+59,966	New	+$2.94M	0.01%	600

Other funds holding ARWR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Ray Dalio's ARWR Position: Q1 2026 in Review

Ray Dalio increased its Arrowhead Research (ARWR) stake by 59% in Q1 2026, buying an estimated $2.25M and bringing the position to 95,552 shares worth $5.99M. The position accounts for 0.03% of the portfolio, ranked #378.

Ray Dalio first reported a position in ARWR in Q4 2025 and has held it in 2 quarters since. 436 funds tracked by Wall St. Rank hold ARWR as of Q1 2026.

Ray Dalio held 95,552 shares of Arrowhead Research worth $5.99M as of Q1 2026.
Ray Dalio bought 35,586 Arrowhead Research shares in Q1 2026, an estimated $2.25M.
Arrowhead Research made up 0.03% of Ray Dalio's portfolio in Q1 2026, its #378 holding.
Ray Dalio first reported a position in Arrowhead Research in Q4 2025 and has held it in 2 quarters since.
436 funds tracked by Wall St. Rank held Arrowhead Research as of Q1 2026.

Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.